白花蛇草、半治连抗头颈部鳞状细胞癌的机制探讨:天然抗癌药物的研究

IF 4.3 3区 化学 Q2 CHEMISTRY, MULTIDISCIPLINARY
ACS Omega Pub Date : 2025-07-31 DOI:10.1021/acsomega.5c03068
Yuchen Zhang, Yuxing Pan and Kunpeng Wang*, 
{"title":"白花蛇草、半治连抗头颈部鳞状细胞癌的机制探讨:天然抗癌药物的研究","authors":"Yuchen Zhang,&nbsp;Yuxing Pan and Kunpeng Wang*,&nbsp;","doi":"10.1021/acsomega.5c03068","DOIUrl":null,"url":null,"abstract":"<p >Head and neck squamous cell carcinoma (HNSCC) is a highly lethal cancer with a poor prognosis. This research assessed the in vitro effectiveness and molecular mechanisms of Bai-Hua-She-She-Cao (BHSSC) and Ban-Zhi-Lian (BZL), a traditional Chinese medicinal herb pair against HNSCC. Bioactive compounds and targets of BHSSC-BZL were identified using the Traditional Chinese Medicine Systems Pharmacology (TCMSP) and Swiss Target Prediction databases and cross-referenced with HNSCC-related targets from GeneCards and MalaCards. Network topology analysis identified hub genes, and The Cancer Genome Atlas (TCGA) data determined the protective and risk factors. Molecular docking verified target specificity, and in vitro experiments assessed BHSSC-BZL effects on CAL27 cell proliferation, apoptosis, and signaling pathways, with validation in SCC-25 cells. The study identified 21 bioactive compounds and 166 potential anti-HNSCC targets, highlighting 22 hub genes associated with cancer pathways, including phosphatidylinositol3-kinase/protein kinase b (PI3K/AKT) signaling and apoptosis regulation. Based on the TCGA data, ATP binding cassette transporter 1 (ABCB1) was identified as a protective factor, while the mesenchymal–epithelial transition factor (MET) was confirmed as a risk factor in HNSCC. Molecular docking analysis revealed that the MET protein could form stable complexes with seven candidate compounds derived from BHSSC-BZL. In vitro experiments further demonstrated that BHSSC-BZL significantly inhibited CAL27 and SCC-25 cell proliferation. BHSSC-BZL demonstrates anti-HNSCC potential by downregulating MET and Bcl-2, upregulating Bax and cleaved-Caspase-9, and inhibiting the PI3K/AKT/mTOR signaling. BHSSC-BZL demonstrates anti-HNSCC activity via a multicomponent, multitarget, and multipathway mechanism, highlighting its potential as a natural antitumor agent.</p>","PeriodicalId":22,"journal":{"name":"ACS Omega","volume":"10 31","pages":"34528–34538"},"PeriodicalIF":4.3000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acsomega.5c03068","citationCount":"0","resultStr":"{\"title\":\"Exploring the Antitumor Mechanisms of Bai-Hua-She-She-Cao and Ban-Zhi-Lian against Head and Neck Squamous Cell Carcinoma: A Study on Natural Anticancer Therapeutics\",\"authors\":\"Yuchen Zhang,&nbsp;Yuxing Pan and Kunpeng Wang*,&nbsp;\",\"doi\":\"10.1021/acsomega.5c03068\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Head and neck squamous cell carcinoma (HNSCC) is a highly lethal cancer with a poor prognosis. This research assessed the in vitro effectiveness and molecular mechanisms of Bai-Hua-She-She-Cao (BHSSC) and Ban-Zhi-Lian (BZL), a traditional Chinese medicinal herb pair against HNSCC. Bioactive compounds and targets of BHSSC-BZL were identified using the Traditional Chinese Medicine Systems Pharmacology (TCMSP) and Swiss Target Prediction databases and cross-referenced with HNSCC-related targets from GeneCards and MalaCards. Network topology analysis identified hub genes, and The Cancer Genome Atlas (TCGA) data determined the protective and risk factors. Molecular docking verified target specificity, and in vitro experiments assessed BHSSC-BZL effects on CAL27 cell proliferation, apoptosis, and signaling pathways, with validation in SCC-25 cells. The study identified 21 bioactive compounds and 166 potential anti-HNSCC targets, highlighting 22 hub genes associated with cancer pathways, including phosphatidylinositol3-kinase/protein kinase b (PI3K/AKT) signaling and apoptosis regulation. Based on the TCGA data, ATP binding cassette transporter 1 (ABCB1) was identified as a protective factor, while the mesenchymal–epithelial transition factor (MET) was confirmed as a risk factor in HNSCC. Molecular docking analysis revealed that the MET protein could form stable complexes with seven candidate compounds derived from BHSSC-BZL. In vitro experiments further demonstrated that BHSSC-BZL significantly inhibited CAL27 and SCC-25 cell proliferation. BHSSC-BZL demonstrates anti-HNSCC potential by downregulating MET and Bcl-2, upregulating Bax and cleaved-Caspase-9, and inhibiting the PI3K/AKT/mTOR signaling. BHSSC-BZL demonstrates anti-HNSCC activity via a multicomponent, multitarget, and multipathway mechanism, highlighting its potential as a natural antitumor agent.</p>\",\"PeriodicalId\":22,\"journal\":{\"name\":\"ACS Omega\",\"volume\":\"10 31\",\"pages\":\"34528–34538\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-07-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://pubs.acs.org/doi/pdf/10.1021/acsomega.5c03068\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Omega\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acsomega.5c03068\",\"RegionNum\":3,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Omega","FirstCategoryId":"92","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsomega.5c03068","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

摘要

头颈部鳞状细胞癌(HNSCC)是一种预后不良的高致死率癌症。本研究评价了中药白花舍舍草(BHSSC)和半治连(BZL)对HNSCC的体外作用及其分子机制。利用中药系统药理学(TCMSP)和瑞士靶标预测数据库,并与GeneCards和MalaCards中的hnscc相关靶标进行交叉比对,鉴定bhsc - bzl的生物活性化合物和靶标。网络拓扑分析确定了枢纽基因,癌症基因组图谱(TCGA)数据确定了保护和危险因素。分子对接验证了靶向特异性,体外实验评估了bhsc - bzl对CAL27细胞增殖、凋亡和信号通路的影响,并在SCC-25细胞中得到了验证。该研究发现了21种生物活性化合物和166个潜在的抗hnscc靶点,突出了22个与癌症通路相关的枢纽基因,包括磷脂酰肌醇3-激酶/蛋白激酶b (PI3K/AKT)信号传导和细胞凋亡调控。根据TCGA数据,ATP结合盒转运蛋白1 (ABCB1)被确定为HNSCC的保护因子,而间充质上皮转化因子(MET)被确认为HNSCC的危险因子。分子对接分析表明,MET蛋白可与bhsc - bzl衍生的7个候选化合物形成稳定的配合物。体外实验进一步证明bhsc - bzl能显著抑制CAL27和SCC-25细胞的增殖。bhsc - bzl通过下调MET和Bcl-2,上调Bax和cleaved-Caspase-9,抑制PI3K/AKT/mTOR信号传导,显示出抗hnscc的潜力。bhsc - bzl通过多组分、多靶点和多途径机制显示出抗hnscc活性,突出了其作为天然抗肿瘤药物的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Exploring the Antitumor Mechanisms of Bai-Hua-She-She-Cao and Ban-Zhi-Lian against Head and Neck Squamous Cell Carcinoma: A Study on Natural Anticancer Therapeutics

Head and neck squamous cell carcinoma (HNSCC) is a highly lethal cancer with a poor prognosis. This research assessed the in vitro effectiveness and molecular mechanisms of Bai-Hua-She-She-Cao (BHSSC) and Ban-Zhi-Lian (BZL), a traditional Chinese medicinal herb pair against HNSCC. Bioactive compounds and targets of BHSSC-BZL were identified using the Traditional Chinese Medicine Systems Pharmacology (TCMSP) and Swiss Target Prediction databases and cross-referenced with HNSCC-related targets from GeneCards and MalaCards. Network topology analysis identified hub genes, and The Cancer Genome Atlas (TCGA) data determined the protective and risk factors. Molecular docking verified target specificity, and in vitro experiments assessed BHSSC-BZL effects on CAL27 cell proliferation, apoptosis, and signaling pathways, with validation in SCC-25 cells. The study identified 21 bioactive compounds and 166 potential anti-HNSCC targets, highlighting 22 hub genes associated with cancer pathways, including phosphatidylinositol3-kinase/protein kinase b (PI3K/AKT) signaling and apoptosis regulation. Based on the TCGA data, ATP binding cassette transporter 1 (ABCB1) was identified as a protective factor, while the mesenchymal–epithelial transition factor (MET) was confirmed as a risk factor in HNSCC. Molecular docking analysis revealed that the MET protein could form stable complexes with seven candidate compounds derived from BHSSC-BZL. In vitro experiments further demonstrated that BHSSC-BZL significantly inhibited CAL27 and SCC-25 cell proliferation. BHSSC-BZL demonstrates anti-HNSCC potential by downregulating MET and Bcl-2, upregulating Bax and cleaved-Caspase-9, and inhibiting the PI3K/AKT/mTOR signaling. BHSSC-BZL demonstrates anti-HNSCC activity via a multicomponent, multitarget, and multipathway mechanism, highlighting its potential as a natural antitumor agent.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
ACS Omega
ACS Omega Chemical Engineering-General Chemical Engineering
CiteScore
6.60
自引率
4.90%
发文量
3945
审稿时长
2.4 months
期刊介绍: ACS Omega is an open-access global publication for scientific articles that describe new findings in chemistry and interfacing areas of science, without any perceived evaluation of immediate impact.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信